Molecular targets on the horizon for kidney and urothelial cancer.

Molecular targets on the horizon for kidney and urothelial cancer.

Item
http://www.wikidata.org/entity/Q38132039
MEK and PI3K inhibition in solid tumors: rationale and evidence to dateElevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial CarcinomaAltered FGF Signaling Pathways Impair Cell Proliferation and Elevation of Palate Shelves.Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers.The route to personalized medicine in bladder cancer: where do we stand?The role of genomics in the management of advanced bladder cancer.Toward personalized management in bladder cancer: the promise of novel molecular taxonomy.Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.The Wide Experience of the Sequential Therapy for Patients with Metastatic Renal Cell Carcinoma.Morphological spectrum of renal cell carcinoma, unclassified: an analysis of 136 cases.Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
P2860

Molecular targets on the horizon for kidney and urothelial cancer.

Item
http://www.wikidata.org/entity/Q38132039
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular targets on the horizon for kidney and urothelial cancer.
@en
type
label
Molecular targets on the horizon for kidney and urothelial cancer.
@en
prefLabel
Molecular targets on the horizon for kidney and urothelial cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Molecular targets on the horizon for kidney and urothelial cancer.
@en
P2093
P2860
P304
P31
P356
10.1038/NRCLINONC.2013.155
P407
P433
P478
P50
P577
P698